Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Lymphoma 2Primary Myelofibrosis 1Polycythemia Vera 1Nasopharyngeal Carcinoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Hereditary Sensory and Autonomic Neuropathies 1Chordoma 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 2sargramostim 1lestaurtinib 1fludarabine phosphate 1Tacrolimus 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Mycophenolic Acid 1Methotrexate 1MLN 8237 1Ketamine 1Flow Cytometry 1Filgrastim 1Carboplatin 1Busulfan 1Antilymphocyte Serum 1Analgesia 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Primary Myelofibrosis × Panobinostat × Clear all
NCT01298934 2015-03-06

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Icahn School of Medicine at Mount Sinai

Phase 1/2 Unknown
22 enrolled
Myeloid

Polycythemia Vera, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡